Stroke Prevention

Stroke Prevention

Edited by  , Edited by 

List price: US$76.49

Currently unavailable

Add to wishlist

AbeBooks may have this title (opens in new window).

Try AbeBooks

Description

The treatment of stroke remains ineffective, and prevention is the key issue for this common disease. Norris and Hachinski have recruited an international group of experts to provide a comprehensive, critical review of the evidence on the primary and secondary prevention of cerebrovascular disease and to translate this information into clinical practice. The authors present fresh information on established risk factors such as atrial fibrillation, smoking and hypertension and on new risk factors such as homocysteinemia and the paradoxical role of alcohol. They cover the protective effects of lifestyle changes, diet, exercise, and estrogen. Under secondary prevention, they deal with aspirin, antiplatelet therapy, surgical measures to prevent stroke, angioplasty and stenting, and the importance of cardiac anomalies increasingly revealed by high-definition imaging. While endarterectomy remains controversial for asymptomatic carotid stenosis, it has been clearly defined as the single most effective strategy in secondary prevention. In a concluding section that will be particularly valuable to clinical readers, the authors provide a lucid, balanced discussion of how the findings from clinical trials, where patients are highly selected, closely monitored, and given the highest standard of care, can be effectively applied in the everyday practice of medicine.show more

Product details

  • Hardback | 364 pages
  • 161 x 240.3 x 25.4mm | 748.44g
  • Oxford University Press Inc
  • New York, United States
  • English
  • numerous line figures
  • 019513382X
  • 9780195133820

Table of contents

1: John W. Norris, Vladimir Hachinski: Prevention of Stroke: A Perspective; Part I: Primary Prevention; 2: Ralph L. Sacco (Columbia University): Stroke Risk Factors: An Overview; 3: Jean-Marc Orgogozo, Serge Renaud (J-MO: University of Bordeaux; SR: INSERM Epidemiology Unit 330): Alcohol and Stroke; 4: E. John Nasrallah, Harold P. Adams (University of Iowa): Lipids and Stroke; 5: Philip A. Wolf (Boston University): Hypertension; 6: David Sherman (University of Texas Health Science Center, San Antonio): Atrial Fibrillation; Philip B. Gorelick (Rush Medical College): Prevention and Screening Programs; 7: Diana B. Petitti (Kaiser Permanente Southern California): Hormones and Stroke Prevention; Part II: Secondary Prevention; 8: G. Devuyst, J. Bogousslavsky (University of Lausanne): Cardiac Anomalies; 9: Natan M. Bornstein (Tel Aviv Medical Center): Acetylsalicylic Acid - Aspirin; 10: J. Donald Easton (Brown University): Antiplatelet Therapy; 11: H.J.M. Barnett, Heather E. Meldrum (John P. Robarts Research Institute, Canada): Surgical Measures to Prevent Stroke; 12: Martin M. Brown (Institute of Neurology, University College, London): Angioplasty and Stenting; Part III: Prevention: Policy and Practice; 13: Ruth Bonita (World Health Organization): Stroke Prevention: A Global Perspective; 14: Geoffrey A. Donnan (National Stroke Research Institute, The University of Melbourne): From Clinical Trials to Clinical Practice; 15: Thomas E. Feasby (University of Calgary): The Appropriateness and Effectiveness of Stroke Prevention; 16: Graeme J. Hankey (University of Western Australia): Policy and Practice in the Prevention of Stroke: Between the Ideal and the Affordable; John W. Norris, Vladimir Hachinski: Epilogue.show more